Clinical Trials for Ferring Pharmaceuticals

Explore 22 clinical trials worldwide

Showing 1-22 of 22 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ferring Pharmaceuticals

Clinical Trials (22)

NCT07152730
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
PHASE1Recruiting
180 participants
Started: Sep 12, 2025 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT07153367
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
PHASE2Not yet recruiting
80 participants
Started: Sep 1, 2025 · Completed: Dec 1, 2027
2 conditions2 sponsors5 locations
NCT07029451
To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice
N/ARecruiting
2,500 participants
Started: Aug 5, 2025 · Completed: Sep 30, 2028
1 condition1 sponsor2 locations
NCT06997900
Menopur And Rekovelle Combination Study Version 2.0
PHASE2Recruiting
200 participants
Started: Jul 4, 2025 · Completed: Aug 31, 2027
3 conditions2 sponsors2 locations
NCT06668493
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
PHASE1/PHASE2Recruiting
20 participants
Started: Jun 12, 2025 · Completed: Nov 30, 2029
1 condition1 sponsor3 locations
NCT07154888
Fast Track to Fertility
NARecruiting
160 participants
Started: Apr 25, 2025 · Completed: Apr 25, 2027
1 condition2 sponsors1 location
NCT06545955
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
PHASE3Recruiting
250 participants
Started: Oct 1, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor21 locations
NCT06510374
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
PHASE3Recruiting
454 participants
Started: Oct 1, 2024 · Completed: Jun 30, 2031
1 condition1 sponsor43 locations
NCT06561958
Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings
N/ARecruiting
1,500 participants
Started: Aug 27, 2024 · Completed: Aug 1, 2027
1 condition1 sponsor31 locations
NCT06280677
Aurora Test for ART Donor Patients (AURORA-Donor)
N/ARecruiting
160 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT05915104
Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis
PHASE2Not yet recruiting
80 participants
Started: Jan 1, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors0 locations
NCT06026332
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
N/ARecruiting
400 participants
Started: Sep 15, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor31 locations
NCT05835219
REBYOTA™ Prospective Registry
N/ARecruiting
200 participants
Started: Jun 19, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor42 locations
NCT05704244
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE3Active, not recruiting
25 participants
Started: Dec 21, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor24 locations
NCT05555121
Rescue Progesterone Supplementation During Frozen Embryo Transfer
PHASE2Active, not recruiting
150 participants
Started: Dec 1, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT06545877
REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)
N/ARecruiting
500 participants
Started: Sep 16, 2022 · Completed: Jun 22, 2029
1 condition1 sponsor1 location
NCT04113382
Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 23, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT03908099
Fit-for-Fertility Multicenter Randomized Controlled Trial
NAActive, not recruiting
408 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2029
2 conditions3 sponsors5 locations
NCT04340024
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
N/ARecruiting
5,000 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2026
3 conditions6 sponsors1 location
NCT02020070
Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy
PHASE2Active, not recruiting
16 participants
Started: Dec 18, 2013 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT01994239
Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy
PHASE2Active, not recruiting
120 participants
Started: Dec 31, 2012 · Completed: Mar 31, 2025
1 condition2 sponsors39 locations
NCT01851018
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment
NAActive, not recruiting
30 participants
Started: May 31, 2012 · Completed: Jun 30, 2025
1 condition2 sponsors1 location